EP4110829 - DIMERIC ANTIGEN RECEPTORS (DAR) THAT BIND CD20 [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 02.12.2022 Database last updated on 02.09.2024 | |
Former | The international publication has been made Status updated on 03.09.2021 | Most recent event Tooltip | 04.05.2024 | Supplementary search report | published on 05.06.2024 [2024/23] | Applicant(s) | For all designated states Sorrento Therapeutics, Inc. 4955 Directors Place San Diego, California 92121 / US | [2023/01] | Inventor(s) | 01 /
JI, Henry Hongjun 4955 Directors Place San Diego, California 92121 / US | 02 /
GUO, Wenzhong 4955 Directors Place San Diego, California 92121 / US | 03 /
ZHANG, Yanliang 4955 Directors Place San Diego, California 92121 / US | 04 /
DING, Bei Bei 4955 Directors Place San Diego, California 92121 / US | 05 /
KAUFMANN, Gunnar F. 4955 Directors Place San Diego, California 92121 / US | [2023/01] | Representative(s) | Script Intellectual Property LLP Suite J, Anchor House School Close Chandlers Ford Eastleigh, Hampshire SO53 4DY / GB | [N/P] |
Former [2023/01] | Script IP Limited Turnpike House 18 Bridge Street Frome Somerset BA11 1BB / GB | Application number, filing date | 21761626.7 | 26.02.2021 | [2023/01] | WO2021US20089 | Priority number, date | US202062982348P | 27.02.2020 Original published format: US 202062982348 P | US202063089869P | 09.10.2020 Original published format: US 202063089869 P | [2023/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021174124 | Date: | 02.09.2021 | Language: | EN | [2021/35] | Type: | A1 Application with search report | No.: | EP4110829 | Date: | 04.01.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.09.2021 takes the place of the publication of the European patent application. | [2023/01] | Search report(s) | International search report - published on: | US | 02.09.2021 | (Supplementary) European search report - dispatched on: | EP | 03.05.2024 | Classification | IPC: | C07K19/00, C07K16/28, C12N15/63 | [2023/01] | CPC: |
C07K14/7051 (EP,US);
C07K16/2887 (EP,US);
A61K2239/38 (EP,US);
A61K2239/48 (EP,US);
A61K39/4611 (EP,US);
A61K39/4631 (EP,US);
A61K39/464424 (EP,US);
A61P35/00 (US);
C07K14/70521 (EP,US);
C07K14/70578 (EP);
C12N15/625 (US);
C12N15/907 (US);
C12N5/0636 (EP,US);
C07K2319/00 (EP);
C07K2319/03 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/01] | Title | German: | DIMERE ANTIGENREZEPTOREN (DAR), DIE CD20 BINDEN | [2023/01] | English: | DIMERIC ANTIGEN RECEPTORS (DAR) THAT BIND CD20 | [2023/01] | French: | RÉCEPTEURS ANTIGÉNIQUES DIMÈRES (DAR) SE LIANT À CD20 | [2023/01] | Entry into regional phase | 23.09.2022 | National basic fee paid | 23.09.2022 | Search fee paid | 23.09.2022 | Designation fee(s) paid | 23.09.2022 | Examination fee paid | Examination procedure | 23.09.2022 | Amendment by applicant (claims and/or description) | 23.09.2022 | Examination requested [2023/01] | Fees paid | Renewal fee | 27.06.2023 | Renewal fee patent year 03 | 27.02.2024 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 28.02.2023 | 03   M06   Fee paid on   27.06.2023 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IY]WO2018177967 (HOFFMANN LA ROCHE [CH], et al); | [Y]US2020002400 (YAO YIHONG [CN], et al); | International search | [Y]US2007280881 (BRASLAWSKY GARY R [US], et al); | [XY]WO2019122060 (HOFFMANN LA ROCHE [CH], et al); | [Y]WO2019173837 (SORRENTO THERAPEUTICS INC [US], et al) |